BACK TO TOP
KSE100
171,115.82
-1778.45
(-1.03%)
KSE100PR
52,304.80
-552.93
(-1.05%)
ALLSHR
102,630.81
-743.98
(-0.72%)
KSE30
51,478.54
-641.56
(-1.23%)
KMI30
245,731.79
-3035.82
(-1.22%)
BKTI
47,279.59
-660.98
(-1.38%)
OGTI
35,704.94
-598.06
(-1.65%)
KMIALLSHR
66,650.31
-541.20
(-0.81%)
PSXDIV20
79,163.91
-560.90
(-0.70%)
UPP9
60,585.65
-695.66
(-1.14%)
NITPGI
45,586.52
-569.04
(-1.23%)
NBPPGI
49,531.01
-637.85
(-1.27%)
MZNPI
30,235.06
-350.90
(-1.15%)
JSMFI
42,097.48
-354.64
(-0.84%)
ACI
22,609.69
-253.52
(-1.11%)
JSGBKTI
72,548.24
-1005.30
(-1.37%)
HBLTTI
18,330.55
07-05-2026
5.87
(0.03%)
MII30
22,197.30
-240.89
(-1.07%)
Sitara Peroxide Limited
NON-COMPLIANT
CHEMICAL
Rs.78.90
1.43
(1.85%)
1D
1M
6M
YTD
1Y
3Y
5Y
^ As of Fri, May 8, 2026 4:43 PM
REG
DFC
CSF
ODL
Open
76.01
High
81.00
Low
73.16
Volume
137,792
CIRCUIT BREAKER
69.72 — 85.22
DAY RANGE
73.16 — 81.00
52-WEEK RANGE ^
11.70 — 132.22
Ask Price
0.00
Ask Volume
0
Bid Price
0.00
Bid Volume
0
LDCP
77.47
VAR
48.00
HAIRCUT
60.00
P/E Ratio (TTM) **
24.50
1-Year Change * ^
571.49%
YTD Change * ^
12.27%

No record found

No record found

No record found

Market data powered by capitalstake.com. Provided by PSX. ** Based on unconsolidated financials
  * Returns not adjusted for payouts
  ^The historical stock prices have been adjusted to reflect stock splits to ensure comparability over time.

Company Profile

BUSINESS DESCRIPTION

Sitara Peroxide Limited was incorporated in Pakistan on March 08, 2004 as a public limited company under the Companies Ordinance, 1984. The principal activity of the Company is manufacturing and sale of hydrogen peroxide.

KEY PEOPLE
Imran GhafoorCEO
Muhammad Bin ImranChairperson
Mazhar Ali KhanCompany Secretary
ADDRESS

601-602 Business Centre, Mumtaz Hassan Road,Off. I.I. Chundrigar Road, Karachi.

WEBSITE

www.sitaraperoxide.com.pk

REGISTRAR

THK Associates (Private) Limited, Plot No. 32-C, Jami Commercial Street 2, D.H.A, Phase-VII, Karachi

AUDITOR

RSM Avais Hyder Liaqat Nauman (Chartered Accountants)

Fiscal Year End

June

Equity Profile

Market Cap (000's)
4,347,390.00
Shares
55,100,000
Free Float
33,060,000
Free Float
60.00%

Announcements

Financial Results
Board Meetings
Others
DateTitleDocument
Apr 30, 2026Transmission of Quarterly Report for the Period Ended 31.03.2026 View   PDF
Apr 30, 2026Financial Results for the Quarter Ended 31.03.2026 View   PDF
Mar 5, 2026Transmission of Quarterly Report for the Period Ended 31.12.2025 View   PDF
Mar 2, 2026Financial Results for the Quarter Ended 31.12.2025 View   PDF
Feb 6, 2026Transmission of Quarterly Report for the Period Ended 30.09.2025 View   PDF
DateTitleDocument
Apr 22, 2026Board Meeting 3rdd Quarter View   
Feb 24, 2026Board Meeting View   
Jan 20, 2026Board Meeting First Quarter 30.09.2025 View   
Dec 9, 2025ANNUAL GENERAL MEETING 2025
REVOKED
View   
Dec 8, 2025Board Meeting in Progress View   
DateTitleDocument
Apr 17, 2026Unusual Movement in Price View   PDF
Apr 15, 2026PROGRESS REPORT View   PDF
Jan 28, 2026Appointment of CEO & Chairman View   
Jan 21, 2026Appointment of Chairman & CEO
REVOKED
View   
Jan 21, 2026SPL | Sitara Peroxide Limited -Requisiton by Substantial Shareholder Under Section 162 Read with Section 133 of the Companies Act 2017 for Holding Fresh Election of Directors
REVOKED
PDF

Financials

All numbers in thousands (000's) except EPS

Annual
Quarterly
2025202420232022
Sales14,900823,9981,742,727
Profit after Taxation(222,519)(169,350)(732,555)(341,211)
EPS(4.04)(3.07)(14.39)(6.19)
Q3 2026Q2 2026Q1 2026Q3 2025
Sales
Profit after Taxation(24,221)297,448(49,527)(52,637)
EPS(0.44)5.40(0.90)(0.96)
Data powered by Capital Stake. To provide comparable data, information might have been standardized. The data presented may therefore differ from issuer's annual report and 'as reported' data should be obtained directly from the source issuer. See the Capital Stake Terms of Use.

Ratios

2025202420232022
Gross Profit Margin (%)(1,345.34)(35.24)(3.63)
Net Profit Margin (%)(1,136.58)(88.90)(19.58)
EPS Growth (%)(31.60)78.67(132.47)(1,082.54)
PEG0.18(0.05)0.010.00

Payouts

Financial Reports